Apontis Pharma AG (APPH.DE)

EUR 10.05

(0.0%)

Net Income Summary of Apontis Pharma AG

  • Apontis Pharma AG's latest annual net income in 2023 was -11.3 Million EUR , down -520.27% from previous year.
  • Apontis Pharma AG's latest quarterly net income in 2024 Q2 was 702.79 Thousand EUR , up 109.03% from previous quarter.
  • Apontis Pharma AG reported an annual net income of 2.68 Million EUR in 2022, up 460.79% from previous year.
  • Apontis Pharma AG reported an annual net income of -745.23 Thousand EUR in 2021, up 37.0% from previous year.
  • Apontis Pharma AG reported a quarterly net income of -3.52 Million EUR for 2023 Q2, down -1143.23% from previous quarter.
  • Apontis Pharma AG reported a quarterly net income of -7.78 Million EUR for 2023 Q4, down -120.97% from previous quarter.

Annual Net Income Chart of Apontis Pharma AG (2023 - 2019)

Historical Annual Net Income of Apontis Pharma AG (2023 - 2019)

Year Net Income Net Income Growth
2023 -11.3 Million EUR -520.27%
2022 2.68 Million EUR 460.79%
2021 -745.23 Thousand EUR 37.0%
2020 -1.18 Million EUR 50.58%
2019 -2.39 Million EUR 0.0%

Peer Net Income Comparison of Apontis Pharma AG

Name Net Income Net Income Difference
MPH Health Care AG 29.54 Million EUR 138.257%
Dermapharm Holding SE 62.36 Million EUR 118.123%
Evotec SE -83.91 Million EUR 86.53%
MERCK Kommanditgesellschaft auf Aktien 2.82 Billion EUR 100.4%
PharmaSGP Holding SE 16.39 Million EUR 168.933%
SynBiotic SE -10.63 Million EUR -6.325%